These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 31865063)

  • 1. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced tics: An observational postmarketing study.
    Touafchia D; Montastruc F; Lapeyre-Mestre M; Rousseau V; Chebane L; Revet A
    Hum Psychopharmacol; 2020 Jul; 35(4):e2734. PubMed ID: 32352603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database.
    de Filippis R; Kane JM; Arzenton E; Moretti U; Raschi E; Trifirò G; Barbui C; De Fazio P; Gastaldon C; Schoretsanitis G
    Drug Saf; 2024 Aug; 47(8):745-757. PubMed ID: 38722481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe parkinsonism under treatment with antipsychotic drugs.
    Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
    Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F
    Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone and Parkinsonism: a pharmacovigilance study.
    Montastruc JL; Durrieu G
    Fundam Clin Pharmacol; 2021 Aug; 35(4):781-784. PubMed ID: 33098706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug induced stuttering: pharmacovigilance data.
    Trenque T; Morel A; Trenque A; Azzouz B
    Expert Opin Drug Saf; 2021 Mar; 20(3):373-378. PubMed ID: 33337944
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen and the risk of Parkinsonism: a case/non-case study.
    Montastruc F; Khosrow-Khavar F; de Germay S; Renoux C; Rousseau V; Durrieu G; Montastruc M; Rascol O; Sommet A; Lapeyre-Mestre M; Benevent J; Montastruc JL
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1181-1184. PubMed ID: 29862427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
    Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
    Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.
    Burk BG; DiGiacomo T; Polancich S; Pruett BS; Sivaraman S; Birur B
    Acta Psychiatr Scand; 2023 Jul; 148(1):32-46. PubMed ID: 37194481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
    Chyou TY; Nishtala R; Nishtala PS
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):692-700. PubMed ID: 32301237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data.
    Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B
    Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database.
    Mettler C; Monnet D; Kramkimel N; Tréluyer JM; Mouthon L; Brézin A; Dupin N; Valnet-Rabier MB; Chouchana L; Terrier B
    Ophthalmology; 2021 Dec; 128(12):1748-1755. PubMed ID: 34000304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.